Is Nova Lifestyle, Inc. overvalued or undervalued?
As of May 11, 2020, Nova Lifestyle, Inc. is considered overvalued and risky due to its negative financial metrics, including a P/E ratio and poor returns on capital, significantly lagging behind peers like The Lovesac Co. and Flexsteel Industries, despite a year-to-date return of 103.63% overshadowed by a 1-year decline of 13.84%.
As of 11 May 2020, the valuation grade for Nova Lifestyle, Inc. has moved from attractive to risky, indicating a significant deterioration in its financial outlook. The company is currently considered overvalued, especially given its negative P/E ratio and poor returns on capital, with a ROCE of -52.38% and an ROE of -62.28%. The price-to-book value stands at 2.47, which, in conjunction with its EV to EBITDA of -5.08, suggests that investors are paying a premium for a company that is struggling to generate positive earnings.In comparison to its peers, Nova Lifestyle, Inc. lags significantly behind The Lovesac Co., which has a P/E ratio of 18.56 and an EV to EBITDA of 7.96, indicating a much healthier valuation. Flexsteel Industries, Inc. also presents a more attractive profile with a P/E of 8.01 and an EV to EBITDA of 7.28. Furthermore, Nova's recent stock performance has been poor, with a year-to-date return of 103.63%, but this is overshadowed by a 1-year decline of 13.84%, contrasting sharply with the S&P 500's 10.26% return over the same period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
